ALACHUA, Fla.--(BUSINESS WIRE)--RTI Biologics, Inc. (RTI) (Nasdaq:RTIX), the Florida-based processor of orthopedic, dental, surgical specialties and other biologic implants, announced today that the company’s unaudited 2008 full year revenues are $146.6 million and fourth quarter revenues are $37.3 million, both up slightly from the company’s pre-announcement on Dec. 30, 2008. This compares to 2007 full year revenues of $94.2 million and fourth quarter revenues of $25.5 million. The increase in year-over-year revenues primarily reflects the inclusion of revenues of Tutogen Medical since the completion of the merger on Feb. 27, 2008. Management still expects to be profitable from operations in the fourth quarter.
